Compare Revvity Inc (RVTY) vs Workday Inc (WDAY) Price & Performance

Revvity (RVTY) trades at $154.18, up 0.38% today and near its 52-week high of $158.28. The stock shows a bullish technical trend with strong moving averages and has beaten earnings estimates for the last three quarters. Recent developments include the launch of a new diabetes screening kit in Europe and the acquisition of Human Cell Design to expand its metabolic disease research tools. Revenue remains stable around $2.9 billion, though net income margin is modest at 8.16%.

The outlook is positive with analyst consensus leaning buy (51.72%) and a price target of $132.13, though the current price exceeds it. Key opportunities include diagnostic growth and AI-driven demand, while risks involve premium valuation (P/E 73.15), margin pressures, and exposure to China market volatility. Earnings on November 3, 2026, will be critical for near-term direction.

Workday (WDAY) trades at $186.59, up 1.26% on the day, with a neutral technical signal and key support at $185. The company reported strong earnings beats in recent quarters, with Q3 2026 EPS expected at $2.74. Revenue grew to $8.45B in 2025, and net income margin improved to 12.32%. Recent news includes expansion into the UAE and AI product launches, alongside a 2.5% headcount reduction for strategic realignment.

WDAY presents a mixed outlook: analyst consensus is a Buy with a $202.92 price target, signaling upside potential driven by AI integration and revenue growth. However, risks include execution challenges from restructuring, competitive pressures, and a high P/E ratio of 38.25. Investors should weigh strong fundamentals against near-term volatility and macroeconomic headwinds.